Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Duffy

Showing results (851-860 of 1,071) with videos related to

Pageof 108
Sort By:
Heart, Lung & Circulation|November 14, 2022
Long-Term Valve Durability in Patients Undergoing Transcatheter Aortic Valve ImplantationJulia Stehli, Misha Dagan, Stephen J Duffy, et al.
Hypertension (Dallas, Tex. : 1979)|July 23, 2003
Short- and long-term COX-2 inhibition reverses endothelial dysfunction in patients with hypertensionMichael E Widlansky, Daniel T Price, Noyan Gokce, et al.
Mayo Clinic Proceedings|September 20, 2000
Antiphospholipid syndrome and perioperative hemostatic management of cardiac valvular surgeryW J Hogan, R D McBane, P J Santrach, et al.
Journal of Pharmaceutical Sciences|December 1, 1992
Evaluation of cytotoxicity of some Mannich bases of various aryl and arylidene ketones and their corresponding arylhydrazonesJ R Dimmock, K M Advikolanu, H E Scott, et al.
Oncology Reports|June 10, 2005
Measurement of plasminogen activator system components in plasma and tumor tissue extracts obtained from patients with breast cancer: an EORTC Receptor and Biomarker Group collaborationN Grebenchtchikov, T M Maguire, R Riisbro, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 13, 2006
Survivin expression in breast cancer predicts clinical outcome and is associated with HER2, VEGF, urokinase plasminogen activator and PAI-1B M Ryan, G E Konecny, S Kahlert, et al.
Internal Medicine Journal|June 7, 2022
Outcomes of thrombus aspiration during primary percutaneous coronary intervention for ST-elevation myocardial infarctionKevin Rajakariar, Nick Andrianopoulos, Daniel Gayed, et al.
JACC. Cardiovascular Interventions|July 16, 2010
Is there an obesity paradox after percutaneous coronary intervention in the contemporary era? An analysis from a multicenter Australian registryTerase Lancefield, David J Clark, Nick Andrianopoulos, et al.
The American Journal of Cardiology|June 14, 2008
Rates of stent thrombosis in bare-metal versus drug-eluting stents (from a large Australian multicenter registry)Bryan P Yan, Stephen J Duffy, David J Clark, et al.
Cardiovascular Research|June 5, 2007
Matrix metalloproteinase-3 and coronary remodelling: implications for unstable coronary diseaseAnthony J White, Stephen J Duffy, Anthony S Walton, et al.
Pageof 108

Showing results (851-860 of 1,071) with videos related to

Sort By:
Pageof 108
Heart, Lung & Circulation|November 14, 2022
Long-Term Valve Durability in Patients Undergoing Transcatheter Aortic Valve ImplantationJulia Stehli, Misha Dagan, Stephen J Duffy, et al.
Hypertension (Dallas, Tex. : 1979)|July 23, 2003
Short- and long-term COX-2 inhibition reverses endothelial dysfunction in patients with hypertensionMichael E Widlansky, Daniel T Price, Noyan Gokce, et al.
Mayo Clinic Proceedings|September 20, 2000
Antiphospholipid syndrome and perioperative hemostatic management of cardiac valvular surgeryW J Hogan, R D McBane, P J Santrach, et al.
Journal of Pharmaceutical Sciences|December 1, 1992
Evaluation of cytotoxicity of some Mannich bases of various aryl and arylidene ketones and their corresponding arylhydrazonesJ R Dimmock, K M Advikolanu, H E Scott, et al.
Oncology Reports|June 10, 2005
Measurement of plasminogen activator system components in plasma and tumor tissue extracts obtained from patients with breast cancer: an EORTC Receptor and Biomarker Group collaborationN Grebenchtchikov, T M Maguire, R Riisbro, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 13, 2006
Survivin expression in breast cancer predicts clinical outcome and is associated with HER2, VEGF, urokinase plasminogen activator and PAI-1B M Ryan, G E Konecny, S Kahlert, et al.
Internal Medicine Journal|June 7, 2022
Outcomes of thrombus aspiration during primary percutaneous coronary intervention for ST-elevation myocardial infarctionKevin Rajakariar, Nick Andrianopoulos, Daniel Gayed, et al.
JACC. Cardiovascular Interventions|July 16, 2010
Is there an obesity paradox after percutaneous coronary intervention in the contemporary era? An analysis from a multicenter Australian registryTerase Lancefield, David J Clark, Nick Andrianopoulos, et al.
The American Journal of Cardiology|June 14, 2008
Rates of stent thrombosis in bare-metal versus drug-eluting stents (from a large Australian multicenter registry)Bryan P Yan, Stephen J Duffy, David J Clark, et al.
Cardiovascular Research|June 5, 2007
Matrix metalloproteinase-3 and coronary remodelling: implications for unstable coronary diseaseAnthony J White, Stephen J Duffy, Anthony S Walton, et al.
Pageof 108